Rebecca Halperin Selected Research

Rebecca Halperin Research Topics

2	COVID-19 01/2022 - 11/2021
1	Neoplasms (Cancer) 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021
1	Hypersensitivity (Allergy) 11/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Nervous System Diseases (Neurological Disorders) 09/2012
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Communicable Diseases (Infectious Diseases) 04/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2008
1	Substance-Related Disorders (Drug Abuse) 11/2008

2	VaccinesIBA 01/2022 - 11/2021
2	AntibodiesIBA 11/2021 - 04/2012
1	Messenger RNA (mRNA)IBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	BNT162 VaccineIBA 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Calbindin 1IBA 09/2012
1	Ataxin-1IBA 09/2012
1	CalciumIBA 09/2012
1	Calcium-Binding ProteinsIBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	Mutant Proteins (Protein, Mutant)IBA 09/2012
1	polyglutamineIBA 09/2012
1	Peptides (Polypeptides)IBA 04/2012
1	Cell Adhesion MoleculesIBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 11/2008

1	Liver Transplantation 11/2021
1	Heart Transplantation (Grafting, Heart) 11/2021
1	Kidney Transplantation 11/2021
1	Therapeutics 01/2021
1	Immunotherapy 01/2021